Neuspera integrated sacral neuromodulation system (iSNM) (Neuspera iSNM System): FDA status

Approved Approved Jun 18, 2025. Indication: urge urinary incontinence, battery free sacral neuromodulation. Company: Neuspera Medical.

Regulatory history

All products in the FDA Tracker

Loading today's edition…